Northern Trust’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7M | Sell |
1,156,258
-134,659
| -10% | -$1.25M | ﹤0.01% | 2031 |
|
|
2025
Q1 | $9.46M | Sell |
1,290,917
-23,954
| -2% | -$176K | ﹤0.01% | 2070 |
|
|
2024
Q4 | $11.2M | Buy |
1,314,871
+68,174
| +5% | +$582K | ﹤0.01% | 2058 |
|
|
2024
Q3 | $10.8M | Buy |
1,246,697
+167,420
| +16% | +$1.46M | ﹤0.01% | 2017 |
|
|
2024
Q2 | $7.38M | Buy |
1,079,277
+109,179
| +11% | +$747K | ﹤0.01% | 2171 |
|
|
2024
Q1 | $8.83M | Buy |
970,098
+298,114
| +44% | +$2.71M | ﹤0.01% | 2117 |
|
|
2023
Q4 | $3M | Sell |
671,984
-1,752
| -0.3% | -$7.81K | ﹤0.01% | 2774 |
|
|
2023
Q3 | $2.12M | Buy |
673,736
+11,226
| +2% | +$35.3K | ﹤0.01% | 2907 |
|
|
2023
Q2 | $3.42M | Buy |
662,510
+5,413
| +0.8% | +$27.9K | ﹤0.01% | 2709 |
|
|
2023
Q1 | $3.46M | Buy |
657,097
+1,441
| +0.2% | +$7.59K | ﹤0.01% | 2672 |
|
|
2022
Q4 | $1.84M | Buy |
655,656
+2,779
| +0.4% | +$7.81K | ﹤0.01% | 3046 |
|
|
2022
Q3 | $2.71M | Sell |
652,877
-14,704
| -2% | -$61K | ﹤0.01% | 2842 |
|
|
2022
Q2 | $2.68M | Sell |
667,581
-61,579
| -8% | -$248K | ﹤0.01% | 2887 |
|
|
2022
Q1 | $3.61M | Sell |
729,160
-35,817
| -5% | -$177K | ﹤0.01% | 2773 |
|
|
2021
Q4 | $5.33M | Buy |
764,977
+19,477
| +3% | +$136K | ﹤0.01% | 2636 |
|
|
2021
Q3 | $7.46M | Sell |
745,500
-44,121
| -6% | -$441K | ﹤0.01% | 2480 |
|
|
2021
Q2 | $11.2M | Buy |
789,621
+677
| +0.1% | +$9.6K | ﹤0.01% | 2290 |
|
|
2021
Q1 | $12.9M | Buy |
788,944
+7,374
| +0.9% | +$121K | ﹤0.01% | 2127 |
|
|
2020
Q4 | $16.2M | Buy |
781,570
+99,581
| +15% | +$2.06M | ﹤0.01% | 1938 |
|
|
2020
Q3 | $5.19M | Buy |
681,989
+37,034
| +6% | +$282K | ﹤0.01% | 2507 |
|
|
2020
Q2 | $5.37M | Buy |
644,955
+128,854
| +25% | +$1.07M | ﹤0.01% | 2473 |
|
|
2020
Q1 | $2.56M | Buy |
516,101
+38,718
| +8% | +$192K | ﹤0.01% | 2707 |
|
|
2019
Q4 | $1.89M | Sell |
477,383
-10,040
| -2% | -$39.6K | ﹤0.01% | 3160 |
|
|
2019
Q3 | $1.48M | Buy |
487,423
+67,441
| +16% | +$205K | ﹤0.01% | 3253 |
|
|
2019
Q2 | $1.85M | Buy |
419,982
+13,249
| +3% | +$58.3K | ﹤0.01% | 3117 |
|
|
2019
Q1 | $1.62M | Buy |
406,733
+3,291
| +0.8% | +$13.1K | ﹤0.01% | 3193 |
|
|
2018
Q4 | $1.61M | Buy |
403,442
+14,493
| +4% | +$57.7K | ﹤0.01% | 3163 |
|
|
2018
Q3 | $2.68M | Buy |
388,949
+26,322
| +7% | +$181K | ﹤0.01% | 3062 |
|
|
2018
Q2 | $2.45M | Buy |
362,627
+38,101
| +12% | +$257K | ﹤0.01% | 3094 |
|
|
2018
Q1 | $2.11M | Buy |
324,526
+62,993
| +24% | +$410K | ﹤0.01% | 3073 |
|
|
2017
Q4 | $1.16M | Sell |
261,533
-868
| -0.3% | -$3.86K | ﹤0.01% | 3366 |
|
|
2017
Q3 | $1.62M | Buy |
262,401
+262
| +0.1% | +$1.62K | ﹤0.01% | 3290 |
|
|
2017
Q2 | $2.43M | Buy |
262,139
+30,539
| +13% | +$283K | ﹤0.01% | 3061 |
|
|
2017
Q1 | $2.15M | Buy |
231,600
+32,160
| +16% | +$298K | ﹤0.01% | 3047 |
|
|
2016
Q4 | $1.67M | Sell |
199,440
-10,905
| -5% | -$91.3K | ﹤0.01% | 3183 |
|
|
2016
Q3 | $1.45M | Buy |
210,345
+16,541
| +9% | +$114K | ﹤0.01% | 3215 |
|
|
2016
Q2 | $959K | Buy |
193,804
+30,755
| +19% | +$152K | ﹤0.01% | 3357 |
|
|
2016
Q1 | $1.58M | Buy |
163,049
+281
| +0.2% | +$2.71K | ﹤0.01% | 3095 |
|
|
2015
Q4 | $1.53M | Buy |
162,768
+6,292
| +4% | +$59K | ﹤0.01% | 3176 |
|
|
2015
Q3 | $2.2M | Buy |
156,476
+88,924
| +132% | +$1.25M | ﹤0.01% | 2994 |
|
|
2015
Q2 | $1.42M | Buy |
67,552
+9,082
| +16% | +$191K | ﹤0.01% | 3210 |
|
|
2015
Q1 | $2.46M | Buy |
58,470
+86
| +0.1% | +$3.61K | ﹤0.01% | 3004 |
|
|
2014
Q4 | $1.37M | Buy |
58,384
+47,161
| +420% | +$1.11M | ﹤0.01% | 3288 |
|
|
2014
Q3 | $168K | Buy |
+11,223
| New | +$168K | ﹤0.01% | 3886 |
|